Navigation Links
TorreyPines Therapeutics Initiates Phase II Study of Muscarinic Agonist NGX267 for Treatment of Xerostomia
Date:3/18/2008

icans," said Steven Taylor, Chief Executive Officer of the Sjogren's Syndrome Foundation. "While there are treatments available for xerostomia, there is still a significant need for new therapies that could offer patients less frequent dosing regimens and better tolerability."

About Xerostomia

Xerostomia, or dry mouth, is the result of decreased salivary flow and is a symptom of a number of underlying conditions. Causes of dry mouth include Sjogren's syndrome; radiation treatment to the head and neck; and HIV-related salivary gland disease. Xerostomia can also be a side effect of medications and is associated with aging.

About TorreyPines Therapeutics

TorreyPines Therapeutics is a biopharmaceutical company committed to providing patients with better alternatives to existing therapies through the research, development and commercialization of small molecule compounds. The company's goal is to develop versatile product candidates each capable of treating a number of acute and chronic diseases and disorders such as migraine, chronic pain, muscle spasticity and rigidity, xerostomia and cognitive disorders. The company is currently developing four product candidates, two ionotropic glutamate receptor antagonists and two muscarinic receptor agonists. Further information is available at http://www.torreypinestherapeutics.com.

This press release contains forward-looking statements or predictions, including statements regarding the company's strategic plan for 2008, the versatility of the company's product candidates, the potential of NGX267 as a treatment for xerostomia and the potential timing and scope of clinical trials of NGX267. Such statements are subject to numerous risks, and uncertainties that may cause actual events or results to differ materially from the company's current expectations. Statements regarding TorreyPines Therapeutics' product candidates are subject
'/>"/>

SOURCE TorreyPines Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. TorreyPines Therapeutics to Present at Susquehanna Financial Groups Second Annual SIGnificant Options in Healthcare Conference
2. TorreyPines Therapeutics Reports Third Quarter 2007 Results
3. TorreyPines Therapeutics to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
4. TorreyPines Therapeutics to Present at ThinkEquitys ThinkClinic Conference
5. TorreyPines Therapeutics and Eisai Co., Ltd. Extend Genetics Discovery Collaboration for Alzheimers Disease
6. TorreyPines Therapeutics to Present at ThinkEquitys G5 Conference
7. TorreyPines Therapeutics to Present at the NewsMakers in the Biotech Industry Conference
8. Cell Therapeutics, Inc. (CTI) Invest Northwest Presentation to be Webcast
9. Mercury Therapeutics, Inc: Marquant Appointed to Advise on Strategic and Partnering Opportunities
10. Nile Therapeutics Reports 2007 Fourth Quarter and Full Year Financial Results
11. Halozyme Therapeutics Reports Fourth Quarter and Year End 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... BRUNSWICK , Nueva Jersey , 22 de ... Award for Biomedical Research abre hoy su llamada a ... personas cuya investigación científica ha hecho, o tiene el ... la salud humana. Las nominaciones se aceptarán hasta el ...
(Date:1/22/2015)... 22, 2015  Derma Sciences, Inc. (Nasdaq: ... advanced wound care, announces that AMNIOEXCEL® and AMNIOMATRIX®, ... added to the Premier, Inc. Regenerative Skin Grafting ... the AMNIOEXCEL® and AMNIOMATRIX® product lines, which continue ...
(Date:12/24/2014)... , Dec. 24, 2014  Vermillion, Inc. (Nasdaq: ... gynecologic disease, announced today that the Company closed ... Oracle Investment Management, Jack W. Schuler , ... proceeds were $10.5 million, before offering expenses.  The ...
(Date:12/24/2014)... Earlier this year in a June 24 international ... Stem Cell Technology Center, LLC ( ASCTC ) focused attention ... adult tissue stem cells. His title “Asymmetric Self-Renewal by ... Future,” embodied the essence of his message to congress participants. ...
Breaking Biology Technology:El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5Vermillion Announces Closing of Equity Financing 2Vermillion Announces Closing of Equity Financing 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4
... /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ... endocrine therapy and oncology, today reported that patient follow-up ... Phase 3 program in benign prostatic hyperplasia (BPH) with ... be completed at the end of this week. Therefore, ...
... OpenQ ... & Sullivan , ... New York, NY and Paris, France (PRWEB) June 15, 2009 -- OpenQ, one of the ... the prestigious 2009 Global Pharmaceutical CRM Growth Strategy Leadership of the Year award, presented by ...
... SAN JOSE, Calif., June 15 Finesse Solutions, LLC, San ... bioprocess applications, announced its move from a facility in Santa ... CA. Finesse,s new address is 71 Daggett Drive, San ... all Finesse departments from Irvine, CA to Silicon Valley. , ...
Cached Biology Technology:AEterna Zentaris to Report Data from Safety Study of Phase 3 Program in Benign Prostatic Hyperplasia with Cetrorelix Ahead of Schedule 2AEterna Zentaris to Report Data from Safety Study of Phase 3 Program in Benign Prostatic Hyperplasia with Cetrorelix Ahead of Schedule 3AEterna Zentaris to Report Data from Safety Study of Phase 3 Program in Benign Prostatic Hyperplasia with Cetrorelix Ahead of Schedule 4AEterna Zentaris to Report Data from Safety Study of Phase 3 Program in Benign Prostatic Hyperplasia with Cetrorelix Ahead of Schedule 5OpenQ is Awarded Prestigious Life Sciences Industry Award 2
(Date:12/15/2014)... 2014 Research and Markets ( http://www.researchandmarkets.com/research/87pph8/global_facial ) ... Recognition Market 2015-2019" report to their offering. ... recognition is a technology used for the identification of ... of a person such as nose, jaw edges, mouth, ...
(Date:12/11/2014)... , Dec. 10, 2014  Data Sciences International ... has released a new series of digital telemetry ... toxicology researchers. M series, part of the PhysioTel™ ... the best possible physiologic data when incorporating functional ...
(Date:12/10/2014)... CIE San Diego has launched an innovative trust network and ... coordination among social service and care providers by enabling them ... grant from the Alliance Healthcare Foundation to expand to organizations ... a "Live Well San Diego" partner on December 11 th ...
Breaking Biology News(10 mins):Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3New telemetry implants expected to change how large animal toxicology studies are conducted 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 2Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 3Community Information Exchange San Diego Launches Pilot, Secures $1 Million Expansion Grant, and Becomes a "Live Well San Diego" Partner 4
... (September 1, 2011) Our immune system is capable of ... even decades, after they have first been encountered and defeated. ... we retain the means of making them for a lifetime. ... but researchers at The Wistar Institute have discovered some of ...
... -- Two Kansas State University researchers have been collaborating ... plant species that can offer insights into other plants. ... Katie Hildebrand, doctoral student in plant pathology, Stafford, are ... , a small flowering plant that has a short ...
... Society applauds the government of Santa Fe Province for taking ... hunting of waterfowl, the first such action of its kind ... the regulation requires hunters to reduce usage of lead shot ... lead to the eventual ban of lead shot. Lead ...
Cached Biology News:Persistent immunity: Wistar researchers find signals that preserve anti-viral antibodies 2Persistent immunity: Wistar researchers find signals that preserve anti-viral antibodies 3Mapping a model: International research on plant species appears in journal Nature 2Mapping a model: International research on plant species appears in journal Nature 3Argentina's Santa Fe government reducing lead ammunition for sports hunters 2
... 12 amino acid synthetic peptide whose sequence is derived from ... (amino to carboxy terminus): C - S(338) - K ... - V - A - P - A(348). ... with the polyclonal antibody that reacts with this product and ...
... software provides quick and easy operation of ... Windows-based control. The software is fully ... 21 CFR Part 11 regulations, and compatible ... IRsolutions versatility enables use in high-level ...
... PerkinElmer kit provides reagents for immune complex ... and plasma samples using a combination of ... then neutralized and transferred to microplate wells ... mouse monoclonal antibody to HIV-1 p24. The ...
... is an automated solution for scheduling, performing ... testing for all pipettes and liquid handling ... balance Supports all gravimetric calibration ... 12650, ISO 9000, NCCLS and GLP requirements ...
Biology Products: